Vita（VitaDAO）Project Analysis

1. Institute Review

Pfizer was the first pharmaceutical company to join WEB3 to vote on DAO proposals, and is involved in VitaDAO in many other ways, including deal flow, scientific evaluation, incubation and commercialization. defined as an active and diverse community of contributors, VitaDAO's primary funding focus is on life-extension projects, with over 100 projects funded to date The program has a well-established voting mechanism.

2. Recent breakout point

Pfizer invests in web3+ V-God naming

3. Project Description

VitaDAO aims to extend human lifespan by researching, funding and commercializing longevity therapies in an open and democratic manner.

4. Token Role

4-1. VITA tokens are governance tokens (Ether, ERC20) that grant the right to participate in governance.

4-2. VITA holders decide how to commercialize and bring it to patients

5. Token economic model

5-1. 30% will be allocated to the community for initial Genesis, (10% of the total tokens sold at the Genesis auction (i.e. 6,435,936 VITA), representing nearly 50% of the direct circulating supply after issuance.) .

5-2, 70% of the tokens remain available in the VitaDAO library.

6. Project Highlights

Pfizer invests in web3+ V God nod+ Sun's attention+ Longevity Dao.

7. Investment institutions

Pfizer's venture capital arm, Balaji Srinivasan (former CTO of Coinbase and general partner of a16z), Shine Capital, L1 Digital and others participated in the investment

8. Community

twitter: 16,000 people

9. Future outlook

VITA does not grant IP ownership. Instead it grants full governance rights. As $VITA receives funding for R&D projects and begins to generate data, the value of VitaDAO's IP grows with positive research results. growth of the VitaDAO ecosystem and greater funding availability. This in turn attracts higher quality IP, which in turn funds more projects and further develops the VitaDAO ecosystem.